UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

European heart journal, 2022-01, Vol.43 (4), p.280-299

2022

Volltextzugriff (PDF)

UVA Irradiation of Human Skin Vasodilates Arterial Vasculature and Lowers Blood Pressure Independently of Nitric Oxide Synthase

Journal of investigative dermatology, 2014-07, Vol.134 (7), p.1839-1846

2014

Volltextzugriff (PDF)

Mechanistic science in cardiovascular-oncology: the way forward to maximise anti-cancer drug effects and minimise cardiovascular toxicity

Clinical science (1979), 2021-12, Vol.135 (23), p.2661-2663

2021

Volltextzugriff (PDF)

Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies

Cardiovascular research, 2023-02, Vol.118 (18), p.3451-3466

2023

Volltextzugriff (PDF)

Vascular toxicity associated with anti-angiogenic drugs

Clinical science (1979), 2020-09, Vol.134 (18), p.2503-2520

2020

Volltextzugriff (PDF)

Cancer Therapy-Related Hypertension: A Scientific Statement From the American Heart Association

Hypertension (Dallas, Tex. 1979), 2023-03, Vol.80 (3), p.e46-e57

2023

Volltextzugriff (PDF)

Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients

Circulation research, 2021-04, Vol.128 (7), p.1040-1061

2021

Volltextzugriff (PDF)

Vascular Complications of Cancer Chemotherapy

Canadian journal of cardiology, 2016-07, Vol.32 (7), p.852-862

2016

Volltextzugriff (PDF)

Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials

European journal of heart failure, 2023-04, Vol.25 (4), p.488-496

2023

Volltextzugriff (PDF)

Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in Scotland

BMJ open, 2021-08, Vol.11 (8), p.e050281-e050281

2021

Volltextzugriff (PDF)

Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF

Journal of the American Heart Association, 2021-02, Vol.10 (4), p.e019238-e019238

2021

Volltextzugriff (PDF)

Kidney function and cancer risk: An analysis using creatinine and cystatin C in a cohort study

EClinicalMedicine, 2021-08, Vol.38, p.101030-101030, Article 101030

2021

Volltextzugriff (PDF)

Intravenous iron and SGLT2 inhibitors in iron‐deficient patients with heart failure and reduced ejection fraction

ESC Heart Failure, 2024-08, Vol.11 (4), p.1875-1879

2024

Volltextzugriff (PDF)

Cardiac geometry, as assessed by cardiac magnetic resonance, can differentiate subtypes of chronic thromboembolic pulmonary vascular disease

Frontiers in cardiovascular medicine, 2022-12, Vol.9, p.1004169-1004169

2022

Volltextzugriff (PDF)

Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review

Kidney medicine, 2023-07, Vol.5 (7), p.100672-100672, Article 100672

2023

Volltextzugriff (PDF)

Response by Henriksen et al Regarding Article, "Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial"

Circulation (New York, N.Y.), 2024-05, Vol.149 (22), p.e1221

2024

Volltextzugriff (PDF)

Cardiovascular Effects of a Novel SIRT1 Activator, SRT2104, in Otherwise Healthy Cigarette Smokers

Journal of the American Heart Association, 2013-06, Vol.2 (3), p.e000042-n/a

2013

Volltextzugriff (PDF)

Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer

JACC CardioOncology, 2020-09, Vol.2 (3), p.443-455

2020

Volltextzugriff (PDF)

Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS‐MI): rationale and design

ESC Heart Failure, 2024-08, Vol.11 (4), p.2001-2012

2024

Volltextzugriff (PDF)

The ‘other’ big complication: how chronic kidney disease impacts on cancer risks and outcomes

Nephrology, dialysis, transplantation, 2023-05, Vol.38 (5), p.1071-1079

2023

Volltextzugriff (PDF)

Drug Treatment of Hypertension: Focus on Vascular Health

Drugs (New York, N.Y.), 2016-10, Vol.76 (16), p.1529-1550

2016

Volltextzugriff (PDF)

Cardiotoxic effects of angiogenesis inhibitors

Clinical science (1979), 2021-01, Vol.135 (1), p.71-100

2021

Volltextzugriff (PDF)

EMPEROR-REDUCED reigns while EMPERIAL whimpers

European heart journal, 2021-02, Vol.42 (6), p.711-714

2021

Volltextzugriff (PDF)

Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure

Clinical science (1979), 2021-04, Vol.135 (7), p.991-1007

2021

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(95)

Publikationsform

Sprache

Englisch
(121)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

UVA Irradiation of Human Skin Vasodilates Arterial Vasculature and Lowers Blood Pressure Independently of Nitric Oxide Synthase

Mechanistic science in cardiovascular-oncology: the way forward to maximise anti-cancer drug effects and minimise cardiovascular toxicity

Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies

Vascular toxicity associated with anti-angiogenic drugs

Cancer Therapy-Related Hypertension: A Scientific Statement From the American Heart Association

Hypertension and Prohypertensive Antineoplastic Therapies in Cancer Patients

Vascular Complications of Cancer Chemotherapy

Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials

Pulmonary thromboembolism in hospitalised patients with COVID-19: a retrospective national study of patients managed in critical care and ward environments in Scotland

Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF

Kidney function and cancer risk: An analysis using creatinine and cystatin C in a cohort study

Intravenous iron and SGLT2 inhibitors in iron‐deficient patients with heart failure and reduced ejection fraction

Cardiac geometry, as assessed by cardiac magnetic resonance, can differentiate subtypes of chronic thromboembolic pulmonary vascular disease

Kidney Disease Patient Representation in Trials of Combination Therapy With VEGF-Signaling Pathway Inhibitors and Immune Checkpoint Inhibitors: A Systematic Review

Response by Henriksen et al Regarding Article, "Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I-Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial"

Cardiovascular Effects of a Novel SIRT1 Activator, SRT2104, in Otherwise Healthy Cigarette Smokers

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)

Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer

Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS‐MI): rationale and design

The ‘other’ big complication: how chronic kidney disease impacts on cancer risks and outcomes

Drug Treatment of Hypertension: Focus on Vascular Health

Cardiotoxic effects of angiogenesis inhibitors

EMPEROR-REDUCED reigns while EMPERIAL whimpers

Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure

Suchergebnisse filtern